SEC Company Response from POMDOCTOR Ltd (POM) (CIK 0001877971) (POM) — Mar 13, 2025
POMDOCTOR Ltd (POM) (CIK 0001877971)
Date: March 13, 2025 · CIK: 0001877971 · Accession: 0001213900-25-023545
AI Filing Summary & Sentiment
Letter
Office of Trade & Services Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: POMDOCTOR LIMITED (CIK No. 0001877971) Registration Statement on Form F-1
Dear Mr. Kuhn, Mr. Parker, Mr. Anderegg, Mr. King:
On behalf of our client, POMDOCTOR LIMITED, a foreign private issuer incorporated under the laws of the Cayman Islands (the “Company”), we are filing herewith the Company’s registration statement on Form F-1 (the “Registration Statement”) and certain exhibits via EDGAR with the Securities and Exchange Commission (the “Commission”). The Company is, concurrently with the Registration Statement, filing the draft registration statement on Form F-1 initially confidentially submitted on September 30, 2021 and all amendments thereto that were previously submitted for the non-public review of the staff of the Commission (the “Staff”).
Subject to market conditions and the review of the Staff, the Company plans to file an amendment to the Registration Statement containing the estimated offering size and price range, and to commence marketing activities as soon as legally permissible. The Company would greatly appreciate the Staff’s continued assistance to meet this timeline.
* * *
If you have any questions regarding the Registration Statement, please contact Steve Lin at steve.lin@hankunlaw.com, +86 10 8524 5826 (work) or +86 186 1049 5593 (cell).
Thank you for your time and attention.
Very truly yours,
/s/ Steve Lin
Show Raw Text
CORRESP
1
filename1.htm
March 13, 2025
Mr. Patrick Kuhn
Mr. Joel Parker
Mr. Scott Anderegg
Mr. Dietrich King
Office of Trade & Services
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
POMDOCTOR LIMITED (CIK No. 0001877971)
Registration Statement on Form F-1
Dear Mr. Kuhn, Mr. Parker, Mr. Anderegg, Mr. King:
On behalf of our client, POMDOCTOR
LIMITED, a foreign private issuer incorporated under the laws of the Cayman Islands (the “Company”), we are
filing herewith the Company’s registration statement on Form F-1 (the “Registration Statement”) and certain
exhibits via EDGAR with the Securities and Exchange Commission (the “Commission”). The Company is, concurrently
with the Registration Statement, filing the draft registration statement on Form F-1 initially confidentially submitted on September 30,
2021 and all amendments thereto that were previously submitted for the non-public review of the staff of the Commission (the “Staff”).
Subject to market conditions
and the review of the Staff, the Company plans to file an amendment to the Registration Statement containing the estimated offering size
and price range, and to commence marketing activities as soon as legally permissible. The Company would greatly appreciate the Staff’s
continued assistance to meet this timeline.
* * *
If you have any questions
regarding the Registration Statement, please contact Steve Lin at steve.lin@hankunlaw.com, +86 10 8524 5826 (work) or +86 186 1049 5593
(cell).
Thank you for your time and
attention.
Very truly yours,
/s/ Steve Lin
Steve Lin
c.c.
Zhenyang Shi, Chief Executive Officer, POMDOCTOR LIMITED
Li Xu, Chief Financial Officer, POMDOCTOR LIMITED
Steve Lin, Esq., Partner, Han Kun Law Offices
LLP
Dinglei Xiao, Partner, Marcum Asia CPAs LLP
Fang Liu, Esq., Partner, VCL Law LLP